Swiss drugmaker Roche said it received an emergency use authorization from the U.S. Food and Drug Administration for an antibody test that can determine if people have ever been infected with the coronavirus and developed antibodies against it.
Roche said its Elecsys Anti-SARS-CoV-2 antibody test has a specificity greater than 99.8% and that it can help assess people’s immune response to the virus.
The company said it has already started shipping the new antibody test to top laboratories globally and will step up production to “high double-digit millions per month.”
